Britain allocates 8.4 million pounds funding for COVID-19 immunity research

Britain has allocated over 8.4 million pounds ($11 million)  funds to support at least three COVID-19 studies in UK, according to reports. UK Research and Invation and  National Institute for Health Research, has sought to assist scientists in funding to accelerate research into SARS-CoV-2 varying symptoms in different patients. research would help medical fraternity decode why some people’s bodies have better immunity response to respiratory virus over ors, for who, it might prove to be life-threatening. 

In a joint statement on August 27, funding bodies wrote that se studies will improve treatment of patients and inform development of vaccines and rapies. Furr, y ded, most importantly research would determine when and how immunity persists or wher people can become re-infected with COVID-19. As per reports, 6.5 million pounds of total funding will be shared with UK Coronavirus Immulogy Consortium for research into effective immunity development and response. Ar 1.5 million would be allocated for humoral immune response molecules that strengn immune system to fight disease. A total of 400,000 pounds is allowed for COVID-19 research and its impact on lungs and or organs. 

Re: Greece Battles Coronavirus Resurgence After Early Success

Re: Rapid $5 Coronavirus Test Doesn't Need Specialty Equipment

In one such research conducted by University of Oxford clinical scientists Martin Landray and Peter Horby, physicians around world are being vised on drugs for treatment of critical patients of COVID-19 in ER. As per research published in American Association for vancement of Science, health experts at UK megatrial called Recovery, have been testing existing drugs as rapies for coronavirus. pair ministered lopinavir and ritonavir, two antivirals kwn to curb HIV, and studied data of 1596 patients. In a press release,  investigators anunced that significant difference in death rate and vised health practitioners accordingly. “This could have worked. And it was a bust,” Eric Topol, director of Scripps Research Translational Institute said in study. “It was really important to clarify that,” he ded.

Breakthrough Dexamethasone

Earlier in same month, Recovery (Randomised Evaluation of COVID-19 rapy) delivered results on two treatments for COVID-19. A breakthrough treatment of dexamethasone, a cheap steroid, was found to have reduced deaths by one-third in patients on a ventilator. Investigators also found that hydroxychloroquine, antimalarial drug controversially touted by President Trump for COVID-19, did t have desired response on hospitalized patients.

Re: French PM Makes Face Mask Compulsory In Paris To Curb New Wave Of Coronavirus

Re: COVID-19: Scientists Decode How Severe Viral Infections Derail Immune System